# Alveo Technologies

> Alveo Technologies makes a portable molecular testing system for detecting pathogens at the point of need. Its commercial poultry test identifies avian influenza Type A and differentiates H5, H7 or H9 in about 45 minutes, pairing a reusable analyzer and disposable cartridge with a phone app and optional cloud reporting. It sells through veterinary and distribution partners while adapting the platform to human health, livestock and industrial uses.

- **Founded:** 2014
- **Headquarters:** Alameda, United States
- **Founders:** Ron Chiarello (Co-founder and former CEO), Lawrence Blatt (Co-founder), Mike Aicher (Co-founder)
- **Products:** Alveo Sense Poultry Avian Influenza Test, Alveo Analyzer and Sense app, be.well human diagnostics platform, Partner assay development
- **Notable:** Named one of five grand-prize winners in the 2021 XPRIZE Rapid COVID Testing competition., Published 2025 laboratory validation of its bird-side avian influenza assays., Announced commercial launch of Alveo Sense Poultry in Europe and the Middle East in 2024.

## Products & services

- **Alveo Sense Poultry Avian Influenza Test** — Veterinary-use multiplex molecular cartridge panels detecting influenza Type A and differentiating H5 and H7 or H5 and H9 from poultry swabs in about 45 minutes; sold where locally approved, not in the United States.
- **Alveo Analyzer and Sense app** — Reusable palm-sized reader with Bluetooth-linked smartphone workflow and results; can connect to Alveo Vista for geotagged reporting.
- **be.well human diagnostics platform** — Human-use platform and assays under development, including a CDC-supported test for seasonal influenza A and B and A(H5).
- **Partner assay development** — Co-development of pathogen assays on Alveo’s platform with industry and academic partners, followed by joint commercialization where applicable.

## Achievements

- Named one of five grand-prize winners in the 2021 XPRIZE Rapid COVID Testing competition.
- Published 2025 laboratory validation of its bird-side avian influenza assays.
- Announced commercial launch of Alveo Sense Poultry in Europe and the Middle East in 2024.
- Announced Egypt deployment plan for 1,000 analyzers and 10,000 cartridges in 2025.

## Latest updates

- **2026-09** — Royal GD expanded its collaboration with Alveo to develop swine, cattle and additional poultry assays; the partners expect expanded offerings by 2027.
- **2026-09** — Alliance Global signed a distribution agreement for Africa, Central Asia and selected Eastern Mediterranean countries.
- **2026-08** — Alveo and AgriNerds announced a project combining on-farm testing with migratory-bird risk scoring.
- **2026-05** — CEPI awarded a grant to explore Alveo’s platform for vaccine manufacturing.

## Links

- Website: https://www.alveotechnologies.com
- LinkedIn: https://www.linkedin.com/company/alveo-technologies/
- Twitter/X: https://twitter.com/alveotech
- Facebook: https://facebook.com/Alveo-Technologies-115196450178969/

---

Profile page: https://yespress.io/alveo
Published by YesPress — https://yespress.io
Last updated: 2026-09-30